Financial results - UROSAB MED S.R.L.

Financial Summary - Urosab Med S.r.l.
Unique identification code: 44554741
Registration number: J29/1684/2021
Nace: 8622
Sales - Ron
89.578
Net Profit - Ron
57.233
Employee
2
The most important financial indicators for the company Urosab Med S.r.l. - Unique Identification Number 44554741: sales in 2023 was 89.578 euro, registering a net profit of 57.233 euro and having an average number of 2 employees. Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala specializata having the NACE code 8622.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Urosab Med S.r.l.

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR - - - - - - - 0 66.611 89.578
Total Income - EUR - - - - - - - 0 66.611 89.578
Total Expenses - EUR - - - - - - - 2.211 15.361 31.495
Gross Profit/Loss - EUR - - - - - - - -2.211 51.250 58.083
Net Profit/Loss - EUR - - - - - - - -2.211 50.119 57.233
Employees - - - - - - - 1 1 2
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales increased by 34.9%, from 66.611 euro in the year 2022, to 89.578 euro in 2023. The Net Profit increased by 7.266 euro, from 50.119 euro in 2022, to 57.233 in the last year.

Check the financial reports for the company - Urosab Med S.r.l.

Rating financiar

Financial Rating -
Urosab Med S.r.l.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Urosab Med S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Urosab Med S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Urosab Med S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Urosab Med S.r.l. - CUI 44554741

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets - - - - - - - 0 10.859 7.935
Current Assets - - - - - - - 178 46.831 45.334
Inventories - - - - - - - 0 0 0
Receivables - - - - - - - 0 32.309 33.603
Cash - - - - - - - 178 14.522 11.732
Shareholders Funds - - - - - - - -2.170 47.942 48.531
Social Capital - - - - - - - 40 41 40
Debts - - - - - - - 2.349 9.748 4.738
Income in Advance - - - - - - - 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 45.334 euro in 2023 which includes Inventories of 0 euro, Receivables of 33.603 euro and cash availability of 11.732 euro.
The company's Equity was valued at 48.531 euro, while total Liabilities amounted to 4.738 euro. Equity increased by 735 euro, from 47.942 euro in 2022, to 48.531 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Urosab Med S.r.l.

Comments - Urosab Med S.r.l.

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.